Literature DB >> 19932332

Evaluation and management of psoriasis: an internist's guide.

Danielle Levine1, Alice Gottlieb.   

Abstract

Psoriasis is a debilitating chronic skin condition that afflicts millions of patients worldwide. Patients experiencing psoriasis report a magnitude of impaired quality of life that is often similar to that of patients who have heart failure and cancer. Many patients who have psoriasis are even themselves at risk for developing heart disease, metabolic syndrome, certain cancers, and psychiatric illness. Therefore, primary care physicians must appreciate the current psoriatic disease model and share a basic understanding of psoriasis management. This article reviews the epidemiology, clinical features, pathogenesis, comorbidities, and treatment of psoriasis, with special emphasis placed on the new class of medications, biologics, which are revolutionizing the management of the disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19932332     DOI: 10.1016/j.mcna.2009.08.003

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  8 in total

Review 1.  Diagnosis and management of psoriasis.

Authors:  Whan B Kim; Dana Jerome; Jensen Yeung
Journal:  Can Fam Physician       Date:  2017-04       Impact factor: 3.275

Review 2.  Oversight and Management of Women with Psoriasis in Childbearing Age.

Authors:  Ștefana Bucur; Alexandra-Petruța Savu; Ana Maria Alexandra Stănescu; Elena-Daniela Șerban; Alin-Codruț Nicolescu; Traian Constantin; Anca Bobircă; Maria-Magdalena Constantin
Journal:  Medicina (Kaunas)       Date:  2022-06-09       Impact factor: 2.948

3.  Recognition of oxidized albumin and thyroid antigens by psoriasis autoantibodies. A possible role of reactive-oxygen-species induced epitopes in chronic plaque psoriasis.

Authors:  Hani A Al-Shobaili; Ahmed A Ahmed; Zafar Rasheed
Journal:  Saudi Med J       Date:  2015-12       Impact factor: 1.484

Review 4.  Burden of Moderate-to-Severe Plaque Psoriasis and New Therapeutic Approaches (Secukinumab): An Italian Perspective.

Authors:  Lorenzo Mantovani; Massimo Medaglia; Patrizio Piacentini; Marcella Tricca; Gino Antonio Vena; Antonietta Vozza; Gabriella Castellino; Alessandro Roccia
Journal:  Dermatol Ther (Heidelb)       Date:  2016-04-15

5.  Effectiveness comparisons of acupuncture for psoriasis: A Bayesian network meta-analysis protocol.

Authors:  Zhi-Yin Xie; Yu Zhou; Sheng Deng; Wei Ding; Xing-Wu Duan; Li-Rong Yang
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

6.  Effectiveness comparisons of traditional Chinese medicine for psoriasis: A Bayesian network meta-analysis.

Authors:  Longjun Wang; Yun Tao; Sheng Deng; Liyuan Chu; Linge Li
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

7.  Deterioration of Health-Related Quality of Life After Withdrawal of Risankizumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis: A Machine Learning Predictive Model.

Authors:  Kim A Papp; Ahmed M Soliman; Nicolae Done; Christopher Carley; Esteban Lemus Wirtz; Luis Puig
Journal:  Dermatol Ther (Heidelb)       Date:  2021-05-21

8.  An Analysis of IL-10, IL-17A, IL-17RA, IL-23A and IL-23R Expression and Their Correlation with Clinical Course in Patients with Psoriasis.

Authors:  Magdalena Kutwin; Monika Migdalska-Sęk; Ewa Brzeziańska-Lasota; Piotr Zelga; Anna Woźniacka
Journal:  J Clin Med       Date:  2021-12-13       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.